- Home
- Products
XADAGO (Safinamide)
XADAGO (Safinamide)
- Medicine Name: XADAGO
- Generic Name: Safinamide
- Dosage Form & Strength: 50 mg and 100 mg tablets
- Manufactured By: Newron Pharmaceuticals SpA
XADAGO (Safinamide) is a monoamine oxidase B (MAO-B) inhibitor indicated as an add-on treatment to a regimen of levodopa/carbidopa for adult patients with Parkinson’s disease who experience “off” episodes.
- Generic Name: Safinamide
- FDA Approval: Yes, approved in 2017
- Dosage Forms: Available in 50 mg and 100 mg tablets
- Administration: Oral use under the guidance of a licensed healthcare provider
For complete details, please refer to the prescribing information provided with the product.
To be filled based on official prescribing info or doctor’s recommendation.
To request XADAGO through Global Rare Meds, the following are required:
- A valid prescription from a registered medical practitioner
- An import permit, if applicable in your country or region
Availability in India:
XADAGO is not commonly stocked in Indian pharmacies and may be available only through named-patient import channels. Global Rare Meds assists in legally importing the medication for patients across India, including cities such as Mumbai, Delhi, Bengaluru, Chennai, Hyderabad, Kolkata, Ahmedabad, and Pune.
Key Support Offered by Global Rare Meds:
- Assistance with regulatory documentation
- Access to genuine medication sourced from Canada, USA, Europe, or Australia
- Transparent pricing and full support until delivery
For price inquiries or order assistance, contact:
📧 info@globalraremeds.com
📞 +91-99675 15602 (Also on WhatsApp)
Global Rare Meds facilitates the international sourcing and supply of XADAGO from trusted pharmaceutical distributors across the globe.
- All medications are dispensed against a valid prescription
- Packaging and dispatch are handled by licensed pharmacists
- Products are delivered to the patient’s address in India and globally
- Fulfillment is managed via our center in Ambernath, Thane District
Q1: Is XADAGO available in India?
A: XADAGO is not readily available in retail pharmacies and may require import under a named-patient program. Global Rare Meds helps facilitate this process in full compliance with applicable regulations.
Q2: How can I order XADAGO from Global Rare Meds?
A: Submit a valid prescription and required documentation. Our team will guide you through the sourcing and import process step-by-step.
Q3: Is XADAGO a cancer medicine?
A: No, XADAGO is used for the treatment of Parkinson’s disease, specifically to manage “off” episodes in patients already on levodopa/carbidopa therapy.
Q4: How long does it take to receive the medicine?
A: Delivery timelines vary based on sourcing location and documentation clearance. On average, delivery takes 7–14 working days after order confirmation.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
